9amHealth

9amHealth, founded in 2021, delivers virtual, whole-body cardiometabolic care for obesity, diabetes and heart conditions across 47 states and Washington, D.C. Its core offering is the Virtual Cardiometabolic Care Program, in which a dedicated team of obesity specialists, pharmacists, dietitians and behavioural health experts builds personalised treatment plans. Prescribed medications are shipped to members' doors, supported by at-home lab testing, connected health devices and unlimited access to specialists through the company's app.

The company reports clinical outcomes including 17.6% weight reduction with GLP-1s over 12 months and a 2.8% reduction in A1c, along with improvements in blood pressure. The operating model spans several technical domains: telehealth care delivery, a digital health application, chronic disease management, connected devices, at-home laboratory testing and pharmacy and medication logistics.

9amHealth describes itself as mission-driven, holding that managing chronic conditions should be affordable, accessible and kind. The team is patient-first by design - many members live with diabetes or have close family members who do - and the approach is whole-body and connected rather than organised around isolated conditions. The stated aim is to help members feel in charge of their health again.